SCHEMBL23635822

SCHEMBL23635822

CCOC(=O)c1sc2cccc(OC)c2c1COc1ccc(C(N)=O)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STING1 Q86WV6 6/20 0.56
GAA P10253 4/20 0.45
MAPT P10636 4/20 0.45
LMNA P02545 4/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
ALDH1A1 P00352 6/20 0.45
KDM4E B2RXH2 4/20 0.45
HPGD P15428 4/20 0.45
HSD17B10 Q99714 3/20 0.45
MAPK1 P28482 2/20 0.45
GLA P06280 1/20 0.45
TSHR P16473 1/20 0.45
PARP10 Q53GL7 4/20 0.42
MEN1 O00255 3/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
KMT2A Q03164 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
USP2 O75604 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23112003 0.89 STING1 (0.56) STING1L3MBTL1PARP10MAOB
SCHEMBL23111965 0.89 ALDH1A1 (0.47) STING1GAAL3MBTL1ALDH1A1KDM4E
SCHEMBL23630772 0.88 STING1 (0.71) STING1MAPTLMNAL3MBTL1PARP10
SCHEMBL23112078 0.87 STING1 (0.55) STING1LMNAPARP10SMN1; SMN2MAOB
SCHEMBL23635796 0.87 ALDH1A1 (0.59) STING1GAALMNAL3MBTL1ALDH1A1
SCHEMBL30697675 0.87 ALDH1A1 (0.59) STING1GAAL3MBTL1ALDH1A1KDM4E
SCHEMBL30313238 0.87 ALDH1A1 (0.59) STING1GAALMNAL3MBTL1ALDH1A1
SCHEMBL23635875 0.87 ALDH1A1 (0.59) STING1GAAL3MBTL1ALDH1A1KDM4E
SCHEMBL23112110 0.87 STING1 (0.54) STING1GAAL3MBTL1ALDH1A1KDM4E
SCHEMBL26780625 0.85 STING1 (0.54) STING1MAPTLMNAL3MBTL1PARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3793988-B1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD (AU) 2023-11-15 EP disclosed
EP-3793988-B1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD (AU) 2023-11-15 EP disclosed
US-20230227423-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD (AU) 2023-07-20 US disclosed
US-20230227423-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD (AU) 2023-07-20 US disclosed
US-20210214333-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD. (AU) 2021-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227423-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING STING1, CGAS, IRF3 STING1 1/4885GAA 3682/4885MAPT 4756/4885
US-20210214333-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING STING1, CGAS, IRF3 STING1 1/4885GAA 3807/4885MAPT 4769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.